TY - JOUR AU - Rahmawati, Cyntiya AU - Nurbaety, Baiq AU - Qiyaam, Nurul AU - Dini, Sulton AU - Maftuhah, Laelatul PY - 2022/03/31 Y2 - 2024/03/28 TI - IAI SPECIAL EDITION: Cost of illness for COVID-19 inpatients in West Nusa Tenggara, Indonesia JF - Pharmacy Education JA - Pharm Educ VL - 22 IS - 2 SE - Special Edition DO - 10.46542/pe.2022.222.6669 UR - https://pharmacyeducation.fip.org/pharmacyeducation/article/view/1594 SP - p. 66-69 AB - <p><strong>Background:</strong> COVID-19 is still a pandemic worldwide, including in Indonesia. The high number of COVID-19 cases, especially in West Nusa Tenggara (NTB), has a financial impact, considering that inpatient costs are borne by the government.</p><p><strong>Objective:</strong> To calculate the cost of illness for COVID-19 inpatients at the NTB Provincial hospital.</p><p><strong>Method:</strong> The method used was the cost of illness from a payer’s perspective. The population consisted of 822 patients.   </p><p><strong>Results:</strong> The total direct medical cost of COVID-19 patients at the NTB Provincial hospital in 2020 was IDR 45,589,962,670, with an average of IDR 55,462,242. The average cost of COVID-19 inpatients without comorbidities was IDR 45,545,441 and IDR 71,926,056 for those with comorbidities.</p><p><strong>Conclusion:</strong> The total cost of illness of COVID-19 in West Nusa Tenggara, Indonesia, was high. Therefore, preventive efforts are needed to reduce the incidence of COVID-19 in Indonesia, especially in West Nusa Tenggara.</p> ER -